Why Zoetis (ZTS) is a Top Momentum Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks Investment Research • 11 hours ago

Zoetis to Participate in the Bank of America Securities 2026 Animal Health Summit

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) will participate in the Bank of America Securities 2026 Animal Health Summit on Thursday, February 26, 2026 at 1:15 p.m. ET. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company. Interested parties can access the live audio webcast by visiting https://investor.zoetis.com/events-presentations. A replay will also be available on the Zoetis website at the conclusion of the event. About Zoetis Zoet.

Business Wire • 13 hours ago

2 Unstoppable Dividend Stocks to Buy Right Now for Less Than $200

Healthcare is an evergreen industry ripe for finding fantastic dividend-growth stocks. The Wegovy pill has breathed new life into Novo Nordisk.

The Motley Fool • Feb 22, 2026

Why Zoetis (ZTS) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Zacks Investment Research • Feb 18, 2026

Zoetis: Why I'm Doubling Down On My Worst 2025 Pick

Zoetis is reiterated as a buy, with a 20% upside to a $159/share fair value, driven by margin expansion and a cheap valuation. ZTS delivered FY 2025 revenue of $9.5B, beating guidance, and presents expanding gross margins (83.5%) and shareholder-friendly share-count reduction via buybacks. International livestock and a robust pipeline (up to 12 blockbusters) provide secular growth tailwinds, offsetting US consumer retrenchment and competitive pressures.

Seeking Alpha • Feb 16, 2026

Impax U.S. Sustainable Economy Fund Q4 2025 Contributors And Detractors

Eli Lilly is included due to its strategic positioning with respect to sustainability opportunities, specifically in HealthCare Access and Innovation. Advanced Micro Devices is owned for its exceptional Corporate Resilience profile and attractive sustainability opportunity set in areas like the Digital Infrastructure build-out. Oracle stands out with a strong sustainability profile, offering notable opportunities in Digital Infrastructure, Education and the development of Enhanced Skills & Innovation.

Seeking Alpha • Feb 16, 2026

Zoetis forecasts strong 2026 profit, revenue on steady pet‑medicine demand

Zoetis on Thursday forecast 2026 adjusted profit and revenue above Wall Street estimates, as demand across its companion-animal portfolio and resilient international markets helped offset softer trends in the United States.

Reuters • Feb 12, 2026

Zoetis Jumps After Pet-Health Outlet Barks Up A Fourth-Quarter Beat

Zoetis stock rose early Thursday after the pet-health company beat fourth-quarter expectations and offered a bullish 2026 earnings view.

Investors Business Daily • Feb 12, 2026

Zoetis Reports Fourth Quarter and Full Year 2025 Results

PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE: ZTS), the world's leading animal health company, today reported its financial results for the fourth quarter and full year 2025 and provided full year guidance for 2026. The company reported revenue of $2.4 billion for the fourth quarter of 2025, an increase of 3% compared with the fourth quarter of 2024. On an organic operational1 basis, revenue for the fourth quarter of 2025 increased 4% compared with the fourth quarter of 2024. Net income.

Business Wire • Feb 12, 2026

Top Wall Street Forecasters Revamp Zoetis Expectations Ahead Of Q4 Earnings

Zoetis Inc. (NYSE: ZTS) will release earnings for its fourth quarter before the opening bell on Thursday, Feb. 12.

Benzinga • Feb 12, 2026